Susan Patricia Schwendner from 1502 Alice St APT 22, Oakland, CA 94612, age 69

Combination Therapy Using Pentafluorobenzenesulfonamides
view source
US Patent:

6355628, Mar 12, 2002
Filed:

Jul 27, 2000
Appl. No.:

09/627041
Inventors:

Susan Schwendner - San Bruno CA
Pieter Timmermans - Redwood City CA
Jacqueline Walling - Burlingame CA
Assignee:

Tularik Inc. - So. San Francisco CA
International Classification:

A61K 3166
US Classification:

514117, 514406, 514471, 514479, 514492
Abstract:

Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic platinum coordination complex such as cisplatin.

Combination Therapy Using Pentafluorobenzenesulfonamides And Antineoplastic Agents
view source
US Patent:

6822001, Nov 23, 2004
Filed:

Nov 2, 2001
Appl. No.:

10/052905
Inventors:

Susan Schwendner - San Bruno CA
Pieter Timmermans - Redwood City CA
Jacqueline Walling - Burlingame CA
Assignee:

Tularik Inc. - South San Francisco CA
International Classification:

A61K 3118
US Classification:

514601, 514 25, 514 27, 514 34, 514 44, 514 49, 514117, 514403, 514404, 514449, 514471, 514472, 514479, 514492, 514588, 514592, 514593, 514595, 514596, 514597, 514598, 514602, 514603, 514604, 514605
Abstract:

Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel.

Combination Therapy Using Pentafluorobenzenesulfonamides And Antineoplastic Agents
view source
US Patent:

20050250854, Nov 10, 2005
Filed:

Nov 23, 2004
Appl. No.:

10/997784
Inventors:

Fengzhi Li - Buffalo NY, US
Xiang Ling - Snyder NY, US
Youcef Rustum - East Amherst NY, US
Susan Schwendner - Berkeley CA, US
Pieter Timmermans - Redwood City CA, US
Jacqueline Walling - Burlingame CA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
Health Research, Inc. - Buffalo NY
International Classification:

A61K031/18
A61K031/7048
A61K031/7072
A61K031/7076
A61K048/00
US Classification:

514602000, 514027000, 514045000, 514049000, 514283000, 514109000, 514410000, 514263310, 514269000
Abstract:

Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent.

Use Of Gallium To Treat Biofilm-Associated Infections
view source
US Patent:

20070231406, Oct 4, 2007
Filed:

Jan 30, 2007
Appl. No.:

11/700289
Inventors:

Louis Bucalo - Miami FL, US
Susan Schwendner - Berkeley CA, US
Uwe Wirtz - Oakland CA, US
Sunil Sreedharan - South San Francisco CA, US
International Classification:

A61K 33/24
US Classification:

424617000
Abstract:

The invention provides methods, compositions, and kits for treatment or prevention of biofilm-associated infections in an individual. Methods of the invention include administration of a gallium-containing composition for treatment of an established biofilm or prevention of formation of a biofilm. Some methods include administration of a gallium-containing composition in conjunction with an antibiotic substance. Some methods include treatment or prevention of an orally-associated biofilm with a gallium-containing composition in the form of a dentrifice, mouthwash, or chewing gum composition.

Combination Therapy Using Pentafluorobenzenesulfonamides And Antineoplastic Agents
view source
US Patent:

20070248692, Oct 25, 2007
Filed:

Mar 16, 2007
Appl. No.:

11/687097
Inventors:

Fengzhi Li - Buffala NY, US
Xiang Ling - Snyder NY, US
Youcef Rustum - East Amherst NY, US
Susan Schwendner - Berkeley CA, US
Pieter Timmermans - Redwood City CA, US
Jacqueline Walling - Carpenters, GB
Assignee:

AMGEN INC. - Thousand Oaks CA
HEALTH RESEARCH, INC. - Buffalo NY
International Classification:

A61K 36/00
A61K 31/18
A61K 31/415
A61P 35/00
A61K 31/44
A61K 35/00
US Classification:

424725000, 424780000, 514293000, 514404000, 514604000
Abstract:

Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent.

Radioiodinated Phospholipid Ether Analogues
view source
US Patent:

57955611, Aug 18, 1998
Filed:

Sep 12, 1994
Appl. No.:

8/304259
Inventors:

Raymond E. Counsell - Ann Arbor MI
Karen L. Meyer - Norman OK
Susan W. Schwendner - Ann Arbor MI
Terushi Haradahira - Fukuoka, JP
Assignee:

The Board of Regents of the University of Michigan - Ann Arbor MI
International Classification:

A61K 5100
A61M 3614
US Classification:

424 177
Abstract:

Novel radioiodinated analogues of naturally-occurring phospholipid ethers are tumor-specific and have a triglycerol backbone structure which, in certain embodiments, is substituted at the 3-position with an alkyl phosphocholine and include a monoiodinated benzoyl side chain substituted at the 2-position in accordance with the general formula: ##STR1## where n=1-15 ##STR2## M=0-15; Z=. sup. 123 I,. sup. 125 I, and. sup. 131 I; Y=NH. sub. 2, NR. sub. 2, and NR. sub. 3, and R=alkyl, aralkyl.

Polyiodinated Triglyceride Analogs As Radiologic Agents
view source
US Patent:

48730750, Oct 10, 1989
Filed:

Sep 10, 1985
Appl. No.:

6/774498
Inventors:

Raymond E. Counsell - Ann Arbor MI
Marc A. Longino - Ann Arbor MI
Jamey P. Weichert - Ann Arbor MI
Susan P. Schwendner - Ann Arbor MI
Assignee:

The University of Michigan - Ann Arbor MI
International Classification:

A61K 4902
C11C 302
US Classification:

424 11
Abstract:

Novel iodinated arylaliphatic triglyceride analogs, as radiologic agents are liver and hepatocyte site-specific. The triglyceride backbone structure is preferably 1,3-disubstituted or 1,2,3-trisubstituted with, in some embodiments, a 3-substituted-2,4,6-triiodophenyl aliphatic chain wherein the chain has a structure similar to naturally occurring fatty acids. In another embodiment, a monoiodophenyl aliphatic chain is utilized. Any position remaining on the triglyceride backbone is substituted with a saturated or unsaturated aliphatic hydrocarbon chain of the type found in naturally occurring fatty acids. The triglyceride analogs can be radioiodinated. In a preferred embodiment, a lipid emulsion is provided as the carrier vehicle.

Radioiodinated Phospholipid Ether Analogues And Methods Of Using Same
view source
US Patent:

53470303, Sep 13, 1994
Filed:

Feb 10, 1992
Appl. No.:

7/833303
Inventors:

Raymond E. Counsell - Ann Arbor MI
Karen L. Meyer - Norman OK
Susan W. Schwendner - Ann Arbor MI
Terushi Haradahira - Fukuoka, JP
Assignee:

The Board of Regents of The University of Michigan - Ann Arbor MI
International Classification:

C07F 909
US Classification:

558169
Abstract:

Novel radioiodinated analogues of naturally-occurring phospholipid ethers are tumor-specific and have a triglycerol backbone structure which, in certain embodiments, is substituted at the 3-position with an alkyl phosphocholine and include a monoiodinated benzoyl side chain substituted at the 2-position in accordance with the general formula: ##STR1## where n= 1-15 ##STR2## m= 0-15; Z=. sup. 123 I,. sup. 125 I, and. sup. 131 I; Y=NH. sub. 2, NR. sub. 2, and NR. sub. 3, and R=alkyl, aralkyl.

Susan Patricia Schwendner